XML 29 R7.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   125,068,601      
Beginning balance at Dec. 31, 2023 $ 265,353 $ 13 $ 467,834 $ (255) $ (202,239)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   790,111      
Issuance of common stock upon exercise of vested stock options 620   620    
Issuance of common stock under employee stock purchase plan (in shares)   247,464      
Issuance of common stock under employee stock purchase plan 524   524    
Stock-based compensation expense 12,701   12,701    
Other comprehensive income 312     312  
Net loss $ (70,780)       (70,780)
Ending balance (in shares) at Dec. 31, 2024 126,106,176 126,106,176      
Ending balance at Dec. 31, 2024 $ 208,730 $ 13 481,679 57 (273,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares) 112,085 112,085      
Issuance of common stock upon exercise of vested stock options $ 58   58    
Issuance of common stock under employee stock purchase plan (in shares)   251,349      
Issuance of common stock under employee stock purchase plan 156   156    
Stock-based compensation expense 6,844   6,844    
Other comprehensive income 186     186  
Net loss $ (59,001)       (59,001)
Ending balance (in shares) at Dec. 31, 2025 126,469,610 126,469,610      
Ending balance at Dec. 31, 2025 $ 156,973 $ 13 $ 488,737 $ 243 $ (332,020)